Drug Type Chemical drugs |
Synonyms High-molecular-weight Fucoidan |
Target |
Mechanism NF-κB activators(Nuclear factor NF-kappa-B complex activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Preclinical | KR | 01 Sep 2024 | |
Immune System Diseases | Preclinical | KR | 01 Sep 2024 |